PelviSoft BioMesh augmentation of rectocele repair: the initial clinical experience in 35 patients

Int Urogynecol J Pelvic Floor Dysfunct. 2005 Jan-Feb;16(1):44-7; discussion 47. doi: 10.1007/s00192-004-1217-x. Epub 2004 Sep 1.

Abstract

Graft materials have been utilized in the repair of posterior vaginal wall defects to enhance anatomical and functional results, and to improve long-term outcomes. We report on our initial series of 35 patients treated with porcine dermal acellular collagen matrix BioMesh (PelviSoft BioMesh, CR Bard, Cranston, R.I., USA), which has alleviated problems with early postoperative vaginal mucosal dehiscence and delayed healing experienced with the use of other graft materials in the posterior vaginal wall.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Biocompatible Materials
  • Collagen
  • Female
  • Follow-Up Studies
  • Gynecologic Surgical Procedures / methods*
  • Humans
  • Middle Aged
  • Rectocele / pathology
  • Rectocele / surgery*
  • Surgical Mesh*
  • Surgical Wound Dehiscence / prevention & control
  • Swine
  • Treatment Outcome

Substances

  • Biocompatible Materials
  • Collagen